Latest Breaking News On - Handelsbanken life science innovation seminar - Page 1 : comparemela.com

Hansa Biopharma to host conference call to provide interim results from Q1 2021 and Business Update News provided by Share this article Share this article LUND, Sweden, April 14, 2021  /PRNewswire/ Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2021 at 8:00 CET on April 22, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.

United statesUnited kingdomCity ofNoord hollandHansa biopharmaPrnewswire hansa biopharmaKlaus sindahlDonato spotaKatja margellKempen life sciences conferenceHead of corporate communicationsNasdaq stockholmRedeye orphan drugs eventProinvestor biotechAnnual general meetingHealthcare conference